We are live on ! Find out more
RCKT icon

Rocket Pharmaceuticals

34 hedge funds and large institutions have $15.9M invested in Rocket Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more call options, than puts

Call options by funds: $33K | Put options by funds: $6K

6% more capital invested

Capital invested by funds: $15M → $15.9M (+$928K)

0.97% more ownership

Funds ownership: 7.3%8.26% (+0.97%)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

33% less funds holding

Funds holding: 5134 (-17)

76% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 21

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
34
Holders Change
-17
Holders Change %
-33.33%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
5
Increased
9
Reduced
12
Closed
21
Calls
$33K
Puts
$6K
Net Calls
+$27K
Net Calls Change
-$828K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
51
Bank of America
North Carolina
-$11K -1,437 Closed
Manulife (Manufacturers Life Insurance)
52
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$2K -200 Closed
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
+$23 +5 New